1. Franco K, Litaker D, Locala J, Bronson D: The Cost of Delirium in the Surgical Patient. Psychosomatics 2001; 42: 68–73
2. Pisani MA, Kong SY, Kasl SV, et al: Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009; 180: 1092–7
3. Ely EW, Shintani A, Truman B, et al: Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004; 291: 1753-62
4. Thomason JW, Shintani A, Peterson JF, et al: Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients. Crit Care 2005; 9: R375-81
5. Ouimet S, Kavanagh BP, Gottfried SB, et al: Incidence, risk factors and consequences of ICU delirium. Intensive Care Med 2007; 33: 66-73
6. Milbrandt EB, Deppen S, Harrison PL, et al: Costs associated with delirium in mechanically ventilated patients. Crit Care Med 2004; 32: 955–62
7. Gunther ML, Morandi A, Krauskopf E, et al: The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: the VISIONS cohort magnetic resonance imaging study. Crit Care Med 2012; 40: 2022-32
8. Kline RP, Pirraglia E, Cheng H, et al: Surgery and Brain Atrophy in Cognitively Normal Elderly Subjects and Subjects Diagnosed with Mild Cognitive Impairment. Anesthesiology 2012; 116: 603-12
9. Hattori H, Kamiya J, Shimada H, et al: Assessment of the risk of postoperative delirium in elderly patients using E-PASS and the NEECHAM Confusion Scale. Int J Geriatr Psychiatry 2009; 24: 1304-10
10. van Eijk MM, van Marum RJ, Klijn IA, et al: Comparison of delirium assessment tools in a mixed intensive care unit. Crit Care Med 2009; 37: 1881-5
11. Spronk PE, Riekerk B, Hofhuis J, et al: Occurrence of delirium is severely underestimated in the ICU during daily care. Intensive Care Med 2009; 35: 1276-80
12. Devlin JW, Skrobik Y, Gélinas C, et al: Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med 2018; 46: e825–73
13. Gamberini M, Bolliger D, Lurati Buse GA, et al: Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery--a randomized controlled trial. Crit Care Med 2009; 37: 1762-8
14. Schweickert WD, Pohlman MC, Pohlman AS, et al: Early physical and occupational therapy in mechanically ventilated, critically ill patients: A randomised controlled trial. Lancet 2009; 373:1874–82
15. Needham DM, Korupolu R, Zanni JM, et al: Early physical medicine and rehabilitation for patients with acute respiratory failure: A quality improvement project. Arch Phys Med Rehabil 2010; 91: 53
16. Trzepacz PT: Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 2000; 5: 132–148
17. de Rooij SE, van Munster BC, Korevaar JC, et al: Cytokines and acute phase response in delirium. J Psychosom Res 2007; 62: 521–5
18. Cerejeira J, Firmino H, Vaz-Serra A, et al: The neuroinflammatory hypothesis of delirium. Acta Neuropathol 2010; 119: 737-54
19. Eikelenboom P, Hoogendijk WJ, Jonker C, et al: Immunological mechanisms and the spectrum of psychiatric syndromes in Alzheimers disease. J Psychiatr Res 2002; 36: 269– 80
20. Barr J, Fraser GL, Puntillo K, Wesley Ely E, et al: Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013; 41: 263-306
21. Adamis D, Treloar A, Martin FC, et al: ApoE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients. Int J Geriatr Psychiatry 2007; 22: 688–94
22. Lemstra AW, Kalisvaart KJ, Vreeswijk R, et al: Pre-operative inflammatory markers and the risk of postoperative delirium in elderly patients. Int J Geriatr Psychiatry 2008; 23: 943–8
23. Kawano T, Eguchi S, Iwata H, et al: Impact of Preoperative Environmental Enrichment on Prevention of Development of Cognitive Impairment following Abdominal Surgery in a Rat Model. Anesthesiology 2015; 123: 160-70
24. Tune L, Coyle JT: Serum levels of Anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry 1980; 37: 293–7
25. Thomas C, Hestermann U, Kopitz J, et al: Serum anticholinergic activity and cerebral cholinergic dysfunction: An EEG study in frail elderly with and without delirium. BMC Neurosci 2008; 9: 86
26. Van Munster BC, Korevaar JC, Zwinderman AH, et al: The association between delirium and the apolipoprotein E epsilon 4 allele: New study results and a meta-analysis. Am J Geriatr Psychiatry 2009; 17: 856–62
27. Žurek J, Fedora M: The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir 2012; 154: 93-103
28. Grandi C, Tomasi CD, Fernandes K, et al: Brain-derived neurotrophic factor and neuron-specific enolase, but not S100β, levels are associated to the occurrence of delirium in intensive care unit patients. J Crit Care 2011; 26: 133-7
29. Sawada Y, Konno A, Nagaoka J, et al: Inflammation-induced reversible switch of the neuron-specific enolase promoter from Purkinje neurons to Bergmann glia. Scientific Reports 2016; 6: 27758
30. Hirai H: Production of the neuron-specific enolase in astrocytes, but not in neurons, under the neuronal inflammation. Journal of Japanese Biochemical Society 2017; 89: 241-3
31. Van Munster BC, Korse CM, de Rooij SE, et al: Markers of cerebral damage during delirium in elderly patients with hip fracture. BMC Neurol 2009; 27: 9-21
32. Khan BA, Zawahiri M, Campbell NL, et al: Biomarkers for delirium--a review. J Am Geriatr Soc 2011; 59: S256-61
33. Ramlawi B, Rudolph JL, Mieno S, et al: Serologic markers of brain injury and cognitive function after cardiopulmonary bypass. Ann Surg 2006; 244: 593-601
34. Beck R, Deek J, Jones J.B, et al: Gel-expanded to gel-condensed transition in neurofilament networks revealed by direct force measurements. Nature Materials 2010; 9: 40-6
35. Shaw G, Yang C, Ellis R, et al: Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem Biophys Res Commun 2005; 336: 1268-77
36. Hayakawa K, Okazaki R, Ishii K, et al: Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study. Spinal Cord 2012; 50: 493-6
37. Ueno T, Ohori Y, Ito J, et al: Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury. Spinal Cord 2011; 49: 333- 6
38. Gresle MM, Liu Y, Dagley LF, et al: Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients. J Neurol Neurosurg Psychiatry 2014; 85: 1209- 13
39. Ganesalingam J, An J, Bowser R, et al: pNF-H is a promising biomarker for ALS. Amyotroph Lateral Scler Frontotemporal Degener 2013; 14: 146-9
40. Matsushige T, Inoue H, Fukunaga S, et al: Serum neurofilament concentrations in children with prolonged febrile seizures. J Neurol Sci 2012; 321: 39-42
41. Hu YY, He SS, Wang XC, et al: Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients. Neurosci Lett 2002; 320: 156-60
42. Natori A, Ogata T, Sumitani M, et al: Potential Role of pNF-H, a Biomarker of Axonal Damage in the Central Nervous System, as a Predictive Marker of Chemotherapy- Induced Cognitive Impairment. Clin Cancer Res. 2015; 21: 1348-52
43. Fuerst D, Shah J, Shah A, et al: Hippocampal sclerosis is a progressive disorder: a longitudinal volumetric MRI study. Ann Neurol 2003; 53: 413-6
44. Mendes NF, Pansani AP, Carmanhaes ERF, et al: The Blood-Brain Barrier Breakdown During Acute Phase of the Pilocarpine Model of Epilepsy Is Dynamic and Time- Dependent. Front Neurol 2019;10: 382
45. Gorter JA, Aronica E, van Vliet EA: The Roof is Leaking and a Storm is Raging: Repairing the Blood-Brain Barrier in the Fight Against Epilepsy. Epilepsy Curr 2019; 19: 177-181
46. Inoue R, Sumitani M, Ogata T, et al: Direct evidence of central nervous system axonal damage in patients with postoperative delirium: A preliminary study of pNF-H as a promising serum biomarker. Neuroscience Letters 2017; 653: 39–44
47. Saxena S, Maze M: Impact on the brain of the inflammatory response to surgery. Presse Med 2018; 47: e73-81
48. Schrijver EJ, de Vries OJ, Verburg A, et al: Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at-risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double-blind, placebo-controlled clinical trial. BMC Geriatr 2014; 14: 96
49. Ely EW, Margolin R, Francis J, et al: Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001; 29: 1370–9
50. Hughes CG, Pandharipande PP, Thompson JL, et al: Endothelial activation and blood- brain barrier injury as risk factors for delirium in critically ill patients. Crit Care Med 2016; 44: e809–17
51. Tomasi CD, Vuolo F, Generoso J, et al: Biomarkers of Delirium in a Low-Risk Community-Acquired Pneumonia-Induced Sepsis. Mol Neurobiol 2017; 54: 722–6
52. Rengel KF, Pandharipande PP, Hughes CG: Postoperative delirium. Presse Med. 2018; 47: e53–64
53. Terrando N, Monaco C, Ma D, et al: Tumor necrosis factor-α triggers a cytokine cascade yielding postoperative cognitive decline. PNAS 2010; 107: 20518-22
54. Gusmao-Flores D, Salluh JI, Chalhub RÁ, et al: The confusion assessment method for the intensive care unit (CAM-ICU) and intensive care delirium screening checklist (ICDSC) for the diagnosis of delirium: a systematic review and meta-analysis of clinical studies. Crit Care 2012; 16: R115
55. Shi Q, Warren L, Saposnik G, et al: Confusion assessment method: a systematic review and meta-analysis of diagnostic accuracy. Neuropsychiatr Dis Treat 2013; 9: 1359- 70
56. Neto AS, Nassar AP Jr, Cardoso SO, et al: Delirium screening in critically ill patients: a systematic review and meta-analysis. Crit Care Ned 2012; 40: 1946-51
57. Nourshargh S, Alon R: Leukocyte migration into inflamed tissues. Immunity 2014; 41: 694-707
58. Scott DW, Patel RP: Endothelial heterogeneity and adhesion molecules N- glycosylation: implications in leukocyte trafficking in inflammation. Glycobiology 2013; 23: 622-33
59. Vainer B, Nielsen OH: Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM- 2, and ICAM-3 in inflammatory bowel disease. Clin Exp Immunol 2000; 121: 242-7
60. Blyth BJ, Farhavar A, Gee C, et al: Validation of serum markers for blood-brain barrier disruption in traumatic brain injury. J Neurotrauma 2009; 26:1497–1507
61. Kanner AA, Marchi N, Fazio V, et al: Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer 2003; 97:2806–13
62. Vachharajani V, Cunningham C, Yoza B, et al: Adiponectin-deficiency exaggerates sepsis-induced microvascular dysfunction in the mouse brain. Obesity (Silver Spring) 2012; 20:498–504
63. Pandharipande PP, Girard TD, Jackson JC, et al: Long-term cognitive impairment after critical illness. N Engl J Med 2013; 369: 1306-16
64. Hshieh TT, Fong TG, Marcantonio ER, et al: Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci 2008; 63: 764-72
65. Naeije G, Depondt C, Meeus C, et al: EEG patterns compatible with nonconvulsive status epilepticus are common in elderly patients with delirium: a prospective study with continuous EEG monitoring. Epilepsy Behav 2014; 36: 18-21
66. Matsuoka Y, Miyake Y, Arakaki H, et al: Clinical utility and validation of the Japanese version of Memorial Delirium Assessment Scale in a psychogeriatric inpatient setting. Gen Hosp Psychiatry 2001; 23: 36-40
67. de la Cruz M, Fan J, Yennu S, et al: The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center. Support Care Cancer 2015; 23: 2427-33
68. Adamis D, Sharma N, Whelan PJ, et al: Delirium scales: A review of current evidence. Aging Ment Health 2010; 14:543-55
69. Shi Q, Warren L, Saposnik G, et al: Confusion assessment method: a systematic review and meta-analysis of diagnostic accuracy. Neuropsychiatric Disease and Treatment 2013; 9: 1359–70
70. Ely EW, Inouye SK, Bernard GR, et al: Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001; 286: 2703–10
71. Peterson JF, Pun BT, Dittus RS, et al: Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc 2006; 54: 479-84
72. Robinson TN, Raeburn CD, Tran ZV, et al: Motor subtypes of postoperative delirium in older adults. Arch Surg 2011; 146: 295-300
73. Marcantonio E, Ta T, Duthie E, et al: Delirium severity and psychomotor types: their relationship with outcomes after hip fracture repair. J Am Geriatr Soc 2002; 50: 850-7
74. American Society of Anesthesiologists. STANDARDS AND GUIDELINES. ASA Physical Status Classification System. Last approved by the ASA House of Delegates on October 15, 2014
75. Mietani K, Sumitani M, Ogata T, et al: Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit. PLoS One 2019; 14: e0222721
論文の公開元へ
